CD70 and acute myeloid leukemia: Future studies aiming to generate novel combinatorial CAR constructs, to increase CD70 expression density on leukemia cell surface, or to improve the persistence of CD70-CAR-T cells in vivo will be needed to optimize CAR T cell responses for AML.